Healthcare provider profile · identity verified

J. Gregory King, MD

Family Practice · BENNINGTON, VT · NPI 1548225857

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	304	64
Atorvastatin Calcium	Atorvastatin Calcium	254	61
Levothyroxine Sodium	Levothyroxine Sodium	248	51
Gabapentin	Gabapentin	191	39
Omeprazole	Omeprazole	189	42
Amlodipine Besylate	Amlodipine Besylate	183	45
Hydrochlorothiazide	Hydrochlorothiazide	153	35
Famotidine	Famotidine	127	28
Metoprolol Succinate	Metoprolol Succinate	126	28
Oxycodone Hcl	Oxycodone Hcl	108	14
Alendronate Sodium	Alendronate Sodium	106	30
Albuterol Sulfate Hfa	Albuterol Sulfate	103	31
Duloxetine Hcl	Duloxetine Hcl	100	23
Tamsulosin Hcl	Tamsulosin Hcl	99	29
Metformin Hcl Er	Metformin Hcl	96	25
Pravastatin Sodium	Pravastatin Sodium	90	17
Metformin Hcl	Metformin Hcl	84	22
Ozempic	Semaglutide	84	20
Clonazepam	Clonazepam	81	11
Trazodone Hcl	Trazodone Hcl	80	20
Losartan Potassium	Losartan Potassium	79	21
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	77	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	suppressed
Indapamide	Indapamide	74	18
Pantoprazole Sodium	Pantoprazole Sodium	73	22
Bupropion Xl	Bupropion Hcl	69	14
Ezetimibe	Ezetimibe	69	19
Rosuvastatin Calcium	Rosuvastatin Calcium	68	18
Tramadol Hcl	Tramadol Hcl	68	suppressed
Eliquis	Apixaban	66	13
Clopidogrel	Clopidogrel Bisulfate	65	18
Trulicity	Dulaglutide	64	14
Montelukast Sodium	Montelukast Sodium	56	12
Pregabalin	Pregabalin	56	suppressed
Ibuprofen	Ibuprofen	55	11
Lorazepam	Lorazepam	54	15
Lovastatin	Lovastatin	48	14
Lamotrigine	Lamotrigine	47	suppressed
Simvastatin	Simvastatin	46	14
Sertraline Hcl	Sertraline Hcl	43	12
Metoprolol Tartrate	Metoprolol Tartrate	42	13
Xarelto	Rivaroxaban	42	suppressed
Fluticasone Propionate	Fluticasone Propionate	41	15
Topiramate	Topiramate	39	suppressed
Synthroid	Levothyroxine Sodium	38	suppressed
Ventolin Hfa	Albuterol Sulfate	38	11
Levetiracetam	Levetiracetam	36	suppressed
Methadone Hcl	Methadone Hcl	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Allopurinol	Allopurinol	31	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	suppressed
Unithroid	Levothyroxine Sodium	31	suppressed
Fentanyl	Fentanyl	29	suppressed
Furosemide	Furosemide	29	suppressed
Carbamazepine	Carbamazepine	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Primidone	Primidone	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Finasteride	Finasteride	25	suppressed
Levoxyl	Levothyroxine Sodium	25	suppressed
Oxcarbazepine	Oxcarbazepine	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Imipramine Hcl	Imipramine Hcl	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Prazosin Hcl	Prazosin Hcl	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Jardiance	Empagliflozin	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Cephalexin	Cephalexin	21	14
Methylprednisolone	Methylprednisolone	21	16
Myrbetriq	Mirabegron	21	suppressed
Potassium Chloride	Potassium Chloride	21	suppressed
Atenolol	Atenolol	19	suppressed
Morphine Sulfate	Morphine Sulfate	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Cilostazol	Cilostazol	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Oxycontin	Oxycodone Hcl	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Carbamazepine Er	Carbamazepine	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Risperidone	Risperidone	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Alprazolam	Alprazolam	11	suppressed
Dapagliflozin	Dapagliflozin Propanediol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Risedronate Sodium Dr	Risedronate Sodium	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error